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1. Introduction
  Echinococcosis, also called hydatid disease or hydatidosis, 
is a zoonosis, and in humans it occurs as a result of infection 
by the larval (metacestode) stages of taeniid cestodes of the 
genus Echinococcus. It is characterized by long-term growth 
of metacestode (larval) stages (hydatid cysts) in internal 
organs (mainly the liver and lungs) of intermediate host 
animals, viz., sheep and goats. Accidentally, eggs are also 
ingested by humans but do not play a role in the natural 
cycle. Six species of Echinococcus have been recognized; 
four are of public health concern, which are  Echinococcus 
granulosus (E. granulosus) causing cystic echinococcosis 
(CE), Echinococcus multilocularis causing alveolar 
echinococcosis, and Echinococcus vogeli and Echinococcus 
oligarthrus causing polycystic echinococcosis; two new 
species have recently been identified: Echinococcus 
shiquicus in small mammals from the Tibetan plateau[1] and 
Echinococcus felidis in African lions[2,3], but their zoonotic 
transmission potential is unknown. The E. granulosus 
infections have been further classified as domestic and 
sylvatic; in the domestic form, sheep serves as the most 
common intermediate host while in the sylvatic form the 
usual intermediate hosts are caribou or moose.
  Human cystic echinococcosis is the most common 
presentation and probably accounts for > 95% of the 
estimated 2-3 million cases in the globe[4]. Despite 
some progress in the control of echinococcosis, this 
zoonosis continues to be a major public health problem 
in several countries, while in many other countries the 
disease constitutes an emerging and re-emerging[5]. 
Current analyses revealed that human CE is re-emerging 
problem with a remarkable economic impact in developed 
countries, viz., Spain[6], and the disease continues to be 
a substantial cause of morbidity and mortality in several 
parts of the globe. The major sources of morbidity are 
pressure effects from cyst size, location in a sensitive 
organ (brain, reproductive tract, bone), or cyst rupture with 
subsequent anaphylaxis or dissemination of the infection. 
This review represents an updated scenario on the transmission cycle, epidemiology, clinical 
features and pathogenicity, diagnosis and treatment, and prevention and control measures of a 
cestode parasite Echincoccus granulosus (E. granulosus) infection causing cystic echinococcosis 
(CE) in humans. Human CE is a serious life-threatening neglected zoonotic disease that occurs 
in both developing and developed countries, and is recognized as a major public health problem. 
The life cycle of E. granulosus involves a definitive host (dogs and other canids) for the adult
E. granulosus that resides in the intestine, and an intermediate host (sheep and other herbivores) 
for the tissue-invading metacestode (larval) stage. Humans are only incidentally infected; since 
the completion of the life cycle of E. granulosus depends on carnivores feeding on herbivores 
bearing hydatid cysts with viable protoscoleces, humans represent usually the dead end for the 
parasite. On ingestion of E. granulosus eggs, hydatid cysts are formed mostly in liver and lungs, 
and occasionally in other organs of human body, which are considered as uncommon sites of 
localization of hydatid cysts. The diagnosis of extrahepatic echinococcal disease is more accurate 
today because of the availability of new imaging techniques, and the current treatments include 
surgery and percutaneous drainage, and chemotherapy (albendazole and mebendazole). But, the 
wild animals that involve in sylvatic cycle may overlap and interact with the domestic sheep-
dog cycle, and thus complicating the control efforts. The updated facts and phenomena regarding 
human and animal CE presented herein are due to the web search of SCI and non-SCI journals.
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The most common affected organs, however, are the liver 
and the lungs where 90% of the echinococcal cysts develop; 
excluding liver and lungs, all the other organs of the human 
body are considered as uncommon sites of localization of the 
hydatid disease. In this review, various aspects of human CE 
are discussed, based upon the current publications, in SCI 
and non-SCI journals, and in scientific websites, by different 
authors from different parts of the globe. 
2. Etiologic identity
  The adult E. granulosus (3-6 mm long) resides in the small 
intestine of the definitive hosts, dogs or other canids[5,7]. 
The adult worm consists of scolex bearing a rostellum with 
double row of numerous hooks, four prominent suckers and 
a short neck region, and the strobilae consist of 3 proglottids; 
usually one immature, one mature and one gravid proglottid 
make up the strobila.
  The E. granulosus exists as a complex of different strains 
that differ in a wide variety of criteria having impact on the 
epidemiology and control of CE. The most important strain 
associated with the human CE appears to be the common 
sheep G1 strain, and is the most cosmopolitan form[5,8]. The 
current molecular characterization of human and animal
E. granulosus isolates, however, demonstrated the 
involnement of the camel G6 strain in causing infection to 
humans[9,10].
3. Epidemiology
  The greatest prevalence of the disease is in regions of the 
temperate countries, and this is an endemic disease in some 
parts of the world, such as South America, North Africa, 
Asia and Australia[11-13]. In the endemic parts, the rate of 
incidence of human CE has been recorded as >50 per 105 
person-years, and 5%-10% prevalence rate as in parts of 
Peru, Argentina, east Africa, central Asia, and China[4]; 
confirmed evidence for the emergence or re-emergence of 
human CE is there in parts of China, central Asia, Eastern 
Europe, and Israel[14]. The incidence of human hydatid 
cysts has been recorded as 18-20 per 105 in Turkey, one of 
the endemic countries of the disease[15]. In Europe, human 
CE occurs in every country or region, where the annual 
incidence of hospital cases vary between <1 and >8 per 105 
population; in the northern part of Italy, the average annual 
CE incidence was recorded as 9.4-5.6/105 inhabitants 
during 2003-2005[16]. However, Moro et al[17] reported 
that the actual prevalence of infection may greatly be 
underestimated by information from different official sources 
of the same geographical region; Figure 1 represents such 
phenomenon in Junin and in the coastal city of Chincha. 
As has been documented in literatures, human CE may 
occur in the subjects in between 1 and 75 year of ages[14]. 
Epidemiologically, CE occurs mostly in poor communities 
raising sheep and other livestock, and involving dogs in 
guarding as well as herding animals. E. granulosus is mainly 
transmitted in a cycle between dog definitive hosts and 
livestock (mainly sheep); the human behaviour also helps 
to perpetuate the domestic cycle of E. granulosus[4]. The 
CE is endemic in India; the foci of the disease exist in this 
country with highest prevalence in Andhra Pradesh and 
Tamil Nadu[18]. Pednekar et al[19] reported, based upon the 
morphological and molecular studied, that Echinococcus of 
buffalo origin is phenotypically and genetically similar to the 
sheep (G1) and Tasmanian sheep (G2) strains of Echinococcus 
supporting its recognition as one species, viz., E. granulosus 
sensu stricto. In India, the annual incidence of human CE 
per 105 persons varies from 1 to 200; it has been reported that 
human CE cases were with various clinical manifestations 
and immense morbidity[20].
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Figure 1. Human cystic echinococcosis cases per 105  from different 
sources of a particular geographic region.
 
4. Transmission cycle
  The life cycles of E. granulosus can be classified as 
domestic, involving the domestic dog as the main definitive 
host and various species of domestic ungulates as 
intermediate hosts, or as sylvatic, involving wild carnivores 
(Foxes, wolves) and Cervidae (elk; Alces alces, reindeer; 
Rangifer tarandus, and red deer; Cervus elaphus) as hosts; 
the sylvatic cycle is reported in limited regions of the world 
such as North America and Eurasia[21]. In many areas of 
endemic infection, domestic and sylvatic life cycles coexist 
or overlap[7].
4.1. Natural cycle
  The E. granulosus life cycle involves carnivores such 
as dogs (as well as wild canids like wolves and foxes) as 
definitive hosts in which the adult E. granulosus develops 
and resides in the small intestine; under natural conditions, 
herbivores mainly sheep (also goat, swine, cattle, horses 
and camels) serve as a suitable intermediate host where 
echinococcal cysts (larval stages) develop in various organs 
and tissues[5,14]. Humans function as accidental intermediate 
hosts, and they are usually the ‘dead end’ for the parasitic 
infection cycle; the consequences of human infection will be 
discussed later in this article.
  Adult E. granulosus worms have been detected in 
various carnivores such as stray and farm dogs, red foxes, 
golden jackals and wolves[22-24]. Dogs play a critical role 
in transition the hydatidosis; the rate of infection with
E. granulosus in stray dogs in Iran shows a prevalence 
of 5% - 49%[25]. The role of wild definitive hosts in the 
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epidemiology of E. granulosus is known[6]: prevalence of 
echinococcosis in wolves was found 14% in Spain, and 
the wolves parasitized with E. granulosus have also been 
found in Belarus, Italy, Finland, and Bulgaria (prevalence 
rate 11.5%-36%); all positive wolves harboured gravid
E. granulosus from the sheep G1 strain. The wild definitive 
hosts may contribute in the transmission of animal (and 
human) CE in domestic cycles (Figure 2), since the G1 
genotype has been found among wild animals. 
Figure 2. Interaction between sylvatic cycle and domestic cycle of
E. granulosus (indicated by bi-directional arrow) (A) In sylvatic cycle 
the definitive hosts acquire infection by scavenging herbivores acting 
as the intermediate hosts, (B) domestic cycle is maintained between 
dogs and sheep, with man as accidental intermediate host (not shown 
here). 
4.2. Acquisition of infection by animals
  Most forms of human CE are transmitted in domestic cycles 
involving dogs and livestock; the most known is the dog-
sheep cycle. In a typical dog-sheep cycle, E. granulosus 
gravid proglotitids or free eggs, which are passed in the 
faeces of infected dogs, are ingested by sheep (while 
grazing in the field contaminated with dog faeces), in which 
hydatid cysts (metacestode larval stages) develop[14]. The 
definitive host becomes infected by ingesting the cyst-
containing organs of the infected intermediate host. Dogs 
usually acquire infection by ingestion of offal (liver and 
lungs) containing hydatid cysts with viable protoscoleces. 
Camels, which have an important role in transmission cycle 
of human CE, usually harbor G6 genotype of E. granulosus[21] 
that has also been reported from humans[26].
4.3. E. granulosus development
  After ingestion by a suitable intermediate host (herbivore: 
sheep), the egg hatches in the small intestine and releases 
a hooked larva called oncosphere. The embryo, by means of 
its six hooks, penetrates the intestinal wall and migrates via 
the blood stream into major filtering organs, such as liver 
and lungs. In these organs, after localization, the oncosphere 
loses the hooks and develops into metacestode (larval 
echinococcal cyst or hydatid cyst) that enlarges gradually, 
producing many protoscoleces (future tapeworm heads) 
and daughter cysts that fill the cyst interior. The cycle is 
completed if the metacestode with fertile protoscoleces 
are eaten (along with the cyst-containing organs of the 
slaughtered parasitized sheep) by a suitable carnivore[27]. 
The different forms of the hydatid cycts may be of fertile, 
sterile and calcified types; occurrence such cysts in different 
organs among various intermediate host animals are 
represented in Figure 3. After ingestion, the protoscolices 
evaginate, attach to the intestinal mucosa, and develop 
into adult stages in 32 to 80 days. Sexual maturity of adult
E. granulosus occurs in the small intestine after 4-5 weeks 
of ingestion of offal containing viable protoscoleces. Eggs 
or gravid proglottids are shed in the faeces, and thus a new 
cycle begins.
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Figure 3. Characteristic of livestock hydatid cysts. 
 
4.4. Prevalence of hydatidosis among herbivores
  The incidence of human CE is closely related to the 
prevalence of the disease in domestic herbivores, and 
currently there are reports on higher prevalence of 
bovine and ovine cystic hydatidosis[28]. The prevalence 
of infection with hydatid cyst in sheep, goats, cattle and 
buffaloes was recorded high in various endemic regions 
for E. granulosus[25,29]; involvement of herbivores as the 
intermediate hosts (bearing cystic hydatidosis) for the 
parasite is shown in Figure 4. Among the intermediate 
hosts, the most commonly infected organs are the lungs and 
liver[22,28,29]; the incidence of hydatid cysts in sheep, goat, 
cattle and camel and the organ involvement are shown in 
Shyamapada Mandal et al./Asian Pacific Journal of Tropical Medicine (2011)253-260256
Figure 5.
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Figure 4. Cystic hydatidosis in animals acting as the intermediate 
hosts of E. granulosus.
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Figure 5. Occurrence of hydatid cysts in different organs of some 
herbivores.
 Rahimi et al[29] reported that the sheep is highly sensitive to 
the E. granulosus sheep G1 strain, and in this intermediate 
host the hydatid cysts are mostly fertile and, hence, the 
infected sheep are potential source of infection to dogs (and 
other carnivores), the reservoirs for human and livestock 
infections; most of the cysts were without protoscolices found 
in cattle having no important role in disease transmission. 
However, in Romania, as has been reported by Morariu 
et al[30], the livestock involved in the transmission pattern 
includes: sheep, cattle and swine. The prevalence of ovine 
cystic hydatidosis was recorded as 82.3% at the beginning 
of the control program in 1986, while in the year 2000 it was 
reduced to 20%[31]. Similar phenomena were seen for the 
other intermediate hosts[30]; the maximum and minimum 
occurrence of the disease has been depicted in the Figure 6.
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Figure 6. Decreasing prevalence of cystic hydatidosis in herbivores.
5. Human infection (zoonotic aspect) of hydatidosis
5.1. Mode of infection
  Humans become exposed to the eggs of the tapeworm 
after close contact with an infected dog or its contaminated 
environment[4]. The infected dogs pass in their feces
E. granulosus eggs that adhere to hairs on the dog, and 
humans become exposed to the eggs after close contact with 
the dog (or its contaminated environment), and (humans) 
infected following accidental ingestion of E. granulosus eggs, 
or children in the course of playful and intimate contact 
with the infected dogs. Indirect transfer of E. granulosus
eggs in contaminated water and uncooked food can also 
cause human infection. Certain human activities (e.g., 
the widespread rural practice of feeding dogs the viscera 
of home-butchered sheep) facilitate transmission of the 
sheep strain and consequently increase the risk of human 
infection[32].
5.2. Development of cyst
  In humans, as in the herbivorous intermediate hosts, 
hydatid cysts of E. granulosus develop mainly the liver and 
lungs as unilocular fluid-filled bladders, but the cysts may 
develop in almost any internal organ or tissue (heart, bone, 
muscle, nervous system) by haematogenous dissemination, 
or in the abdominal cavity[4,15]. It has been documented 
that most primary infections in humans result a single 
hydatid cyst; however, 20%-40% cases are reported to 
have multiple cysts or multiple organ involvement, which 
in the same patient may indicate ingestion of many eggs of 
E. granulosus[20]. Salem et al[27] described human hydatid 
cysts due to E. granulosus infection as fertile, sterile and 
calcified; Figure 7 depicts the occurrence of different forms 
of the cysts in human liver and lungs. The protoscoleces are 
already formed in the fertile cysts, but a proportion of cysts 
does not produce protoscoleces and remain sterile.
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Figure 7. Characteristic of human hydatid cysts.
  As has been recorded in the literatures, the cystic larva 
develops mainly in the liver (70%), in the lungs (20%), 
and 10% of cysts in anywhere of the body[7,33,34]; however, 
Fagzel and Ghanbary[35] documented that the liver is the 
most common site for echinococcal cyst development (> 
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65%), followed by the lungs (25%); the cyst occurs less 
frequently in the spleen and kidneys (3%), and heart, bone 
and brain (1%-2%). The cerebral hydatid cysts (comprising 
1%-2%)[36,37] are classified as primary and secondary: 
primary cyst results from direct infestation of brain by the 
larva without any demonstrable involvement of other organs 
like liver and lungs[38]. Primary cysts are fertile containing 
brood capsules and scolices and their rupture may result in 
recurrent intracranial hydatid cyst; secondary cysts result 
from rupture of hydatid cyst in brain, and are infertile with 
negligible risk of recurrence after their rupture[39]. The 
hydatid cysts, which develop in bones in < 1% cases, were 
found as the most debilitating manifestation of E. granulosus 
infection to humans[40]. The proportion of hydatid cysts that 
occurs in muscle has been reported as 3%-5%; cysts in the 
left gluteus medius measure 4.8-5.6 cm in diameter, while 
the cyst developed in the gastrocnemius muscle was of 10 
cm as has been detected by US and CT[41]. 
  Larval infection (hydatid disease; hydatidosis) is 
characterised by long-term growth of metacestode (hydatid) 
cysts in humans. The diameters of cysts that generally 
increase are variable, 1-5 cm each year. Most E. granulosus 
cysts are 1-15 cm in diameter when they are discovered, but 
some may eventually reach 20 cm[7]. The cyst in a 50-year-
old woman was of 18 cm, with daughter and granddaughter 
cysts,  weighing about 1 kg, and three other cases with cyst 
size 10-18 cm (2 cases) and 20 cm (1 case) were females; 
human CE in pregnancy revealed that hydatid cysts may 
grow bigger due to decreased cell-mediated immunity and 
humoral effects of placental steroids, as has been seen in 
a study that the largest cyst (20 cm) was in the pregnant 
woman[20].
6. Clinical manifestation and pathogenesis
  On ingestion of E. granulosus eggs by human (an 
accidental intermediate host), the embryos escape, penetrate 
the intestinal mucosa, enter the portal circulation, and are 
trapped in the liver; a small number escape the hepatic 
filter, enter the systemic circulation, and are scattered to 
other organs, where the oncospheres develop into fluid-
filled unilocular (hepatic, or extra-hepatic) hydatid cysts.
  The extra-hepatic hydatid cyst disease usually remains 
asymptomatic unless the cyst grows and produces symptoms 
due to pressure, rupture to the pleural or peritoneal cavity, 
secondary infection, or an allergic reaction. Before the slow 
growing echinococcal cysts enlarge sufficiently to cause 
symptoms, 5-20 years elapse; abdominal pain, hepatomegaly 
are the most common symptoms for patients with liver 
echinococcosis[42]. Because the larvae of this organism 
usually develop as discrete single cysts, it is the least severe 
and most treatable form; nevertheless, large or multiple cysts 
may cause irreversible damage to organs, and the rupture or 
puncture of the cyst can seed multiple organs with larvae or 
cause anaphylactic reactions. Cystic hydatidosis of the bone 
is often asymptomatic for a long duration and is usually 
detected only after a sudden fracture, secondary infection or 
neurovascular lesion caused by compression. Hemachander 
et al[20] documented presenting complaints of CE cases 
including pain in abdomen, mass per abdomen, loss of 
appetite and obstructive jaundice.
  The pre-operative complications include rupture of a 
cyst into a bronchus, bacterial infection of the cyst and 
obstructive jaundice, and the major complications after 
surgical resection with hepatic disease include single cases 
of pleural effusion, wound infection, biliary leak, and intra-
abdominal bleeding resulting in a hepatic lobectomy[43]. 
Headache and vomiting due to raised intracranial tension 
are the most common presenting features of cerebral 
hydatid cysts; other manifestations include seizures, visual 
disturbances and ataxia[37,38].
7. Diagnosis
  The useful diagnostic methods for human CE include 
ultrasonography (US), computerized tomography (CT) and 
magnetic resonance imaging (MRI)[41]. The US is the method 
of choice for the detection of both hepatic and extrahepatic 
echinococcal cysts; the sensitivity of this technique ranges 
93%-98%[44]. The CT confirms the diagnosis by detecting the 
presence of daughter cysts and calcification in the cyst-wall; 
CT sensitivity ranges 90%-97%[44]. The MRI adequately 
demonstrates the features of the hydatid cyst; US and CT 
also contribute to pre-surgical diagnosis. The imaging with 
CT (as well as MRI) is central to the diagnosis of cerebral 
hydatid cysts[37]. Contrast enhanced CT scan of thorax is the 
diagnostic modality of choice for pulmonary hydatid cyst, 
and the “air bubble” sign (a relatively newly recognized 
radiological sign) has been reported to be very sensitive 
(85.7%) and specific (96.6%) in establishing diagnosis of 
ruptured, infected hydatid cyst[45,46]. The detection method 
of some extra hepato-pulmonary hydatid cysts along with 
their size and number and the actual localization, as has 
been reported by authors from different parts of the globe, 
are represented in Table 1.
  The serological tests are helpful in making a human CE 
diagnosis. The current gold standard serodiagnosis is based 
on the detection of IgG antibodies to cyst-fluid derived 
native or recombinant antigen B subunits, either in ELISA 
or in immunoblots[4]. A novel 32 kDa EpC1 antigen, which 
is located in the germinal layer of the hydatid cyst and the 
early protoscolex of E. granulosus, demonstrated antibodies 
in 92.2% of preoperative human cases of CE compared with 
84.5% cases detected using native antigen B[4]. Rahimi et 
al[29] assess the performance of antigen B (AgB) isolated 
from different E. granulosus intermediate hosts and from 
different cyst locations for immunodiagnosis of human CE, 
and reported that these increased the diagnostic sensitivity 
and specificity of the assay (Figure 8). Al-Sakee[47] showed 
that E. granulosus induces both cellular and humoral 
immune responses, and the number of peripheral blood CD8 
T cells was significantly increased in cystic echinococcosis 
patients; this may help diagnosis of the disease.
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Figure 8. Diagnostic sensitivity and specificity of different AgB in 
diagnosis of human CE.
8. Treatment
  The current methods of treatment of human CE include 
surgery (consisting of conservative and laparoscopic), and 
percutaneous drainage (consisting of puncture, aspiration, 
injection and re-aspiration; PAIR); these methods are 
mainly helpful for liver cysts. The method alternative to 
PAIR or surgery for the treatment of muscle-, spleen- 
or kidney-cysts include percutaneous drainage without 
re-aspiration[41,48,49]. The risk of anaphylactic reactions 
resulting from percutaneous treatment of echinococcal cysts 
has been found lower than that following administration 
of certain antibiotics, and fear of anaphylactic shock is no 
longer justified as an argument to avoid this therapeutic 
option[50].
  Medical treatment with albendazole and mebendazole 
demonstrated efficacy is useful in the management of 
patients with hydatid cysts in liver and lungs. The combined 
chemotherapy with albendazole and praziquantel has been 
used successfully in the treatment of CE patients, and 
found more effective than monotherapy with these agents. 
Flubendazole alone, or in combination with ivermectin 
was reported effective in CE therapy[51]. Pre-surgical 
chemotherapy of E. granulosus infections reduces the size 
and number of viable protoscolices[52], and as has been 
documented the percutaneous treatment in combination 
with albendazole has been found more effective than 
surgical cystectomy in terms of hospital stay (4.2 and 12.7 
d, respectively) and complication rate (32% and 84%, 
respectively). The most widely used medications include 
mebendazole, albendazole, and praziquantel, but modifying 
the therapeutic approach by offering new pharmacological 
targets should be explored and evaluated[53,54].
9. Prevention and control
  The human CE warrants more attention from clinicians, 
but their coordination with veterinarians and policy makers 
is also required to implement a more effective approach to 
control disease transmission Rojo-Vazquez et al[6]. Infection 
can be prevented through good personal hygiene to prevent 
hand-to-mouth transmission of E. granulosus eggs from 
dogs to humans, avoidance of ingestion of sheep viscera by 
dogs, by tailoring educational programmes, and by providing 
antihelmithic treatment to the definitive and intermediate 
animal hosts.
  The current options for the control and prevention of 
hydatidosis include an effective livestock vaccine, potential 
dog vaccines against the worm E. granulosus, tailoring 
educational programmes, development of improved 
diagnostic tools for animal (definitive and intermediate) 
hosts and human beings, and more effective antiparasitic 
treatments like oxfendazole[4]. The biological cycle can be 
attacked at various points: regular dog deworming, controlled 
sheep slaughtering, vaccination of the intermediate (sheep) 
animal host, and in future vaccination of the definitive 
(dog) animal host[55-62]. However, since the wild animals 
involve in sylvatic cycle, which overlaps and interacts with 
the domestic sheep-dog cycle, this complicates the control 
efforts[6,14].
10. Concluding remarks
  The infection of immature or mature intestinal stages of 
E. granulosus is not cause of morbidity to the definitive 
hosts, whereas the invasion of various organs (mainly liver 
and lungs) of humans and animal intermediate hosts by 
metacestodes can cause severe and fatal cystic hydatid 
disease. The disease is an important zoonosis, and is a 
serious public health and economic problem throughout the 
world.
Table 1
Occurrence of some extrahepato-pulmonary hydatid cysts in humans.
Localization Size Number Detection Country Authors
Retroperitoneal 9 cm 伊4 cm Single US and CT Greece Tepetes et al[59]
Tibia 2.5-5 cm Multiple CT Iran Metanat et al[60] 
Gastrocnemius muscle 10 cm Double CT Turkey Ormeci et al[41]
Gluteus medius muscle < 5-5.6 cm Multiple US and CT Turkey Ormeci et al[41]
Gluteus maximus muscle 6 cm 伊3 cm Single CT Turkey Ormeci et al[41]
Superior rectus muscle 2 cm 伊2 cm Single MRI Pakistan Etaiwi and Mabreh[61]
Space in between right  pelvis and right lumbar 17.5 cm伊12.6 cm Single US India Roychowdhury et al[62]
Ovary 10 cm Single Surgical operation Turkey Vural et al[63]
Spleen, kidney, peritoneal cavity 4 cm 伊3 cm Multiple Laprotomy and US India Shukla et al[64]
Gallbladder 5 cm 伊3 cm Single Surgical operation Morocco Rabbani et al[65]
Vastuslateralis and rectus femoris muscles 17 cm伊3 cm伊5 cm Single CT Hungary Sisak et al[66]
Adductor magnus muscle of the left thigh 13 cm伊8 cm Single MRI US Italy Vicidomini et al[67] 
Right adductor brevis muscle 15 cm伊15 cm Single MRI Lebanon George et al[68]
Left orbit 4 cm伊1.8 cm Single CT and US Tunisia Limaiem et al[39]
Left thigh 10 cm伊5 cm伊4 cm Single CT, US Greece Mogrambi et al[69]
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  It has been reported that the prevalence of hydatidosis 
in urban centres in India has been showing a consistently 
decreasing trend over the past few decades, which is 
possibly due to economic development and improved 
government legislation of abattoirs[19]. A diagnosis of hepatic 
and extra-hepatic echinococcal disease is more accurate 
today because of the new imaging techniques (MRI, CT, US) 
available.
  Study reinforces the importance of preoperative diagnosis 
with CT in preventing rupture of cyst and thus achieving 
optimal outcome as in case of cerebral hydatid cyst. En bloc 
resection without inducing rupture as well as spreading 
the daughter cyst is recommended treatment strategy, 
and accepted to be curative for intramuscular hydatid 
disease[63,64].
  The variation in E. granulosus may affect biology, host 
specificity and pathology, sensitivity to chemotherapeutics, 
and hence design and development of vaccines against
E. granulosus, therefore, characterizing the exact etiological 
agent in different areas is imperative in order to determine 
the transmission patterns and control programs. Control 
programs based on combinations of animal vaccination, 
dehelmintization of dogs, and education programs should 
be implemented to achieve effective prevention of disease 
transmission[65].
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